Related Experiment Videos

Community-acquired pneumonia in children: from diagnosis to treatment

David Greenberg1, Eugene Leibovitz

  • 1The Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. dudi@bgumail.bgu.ac.il

Chang Gung Medical Journal
|January 21, 2006
PubMed

Insights

Community-acquired pneumonia (CAP) in children is a major global health issue, particularly in developing nations. While treatment algorithms have reduced mortality, antimicrobial resistance poses future challenges, highlighting the importance of vaccines.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of illness and death in children globally, especially in developing countries.
  • Etiology varies by age and season, involving viral, bacterial, or mixed infections.
  • Current diagnostic methods like chest X-rays and lab tests lack sufficient accuracy.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and management of childhood CAP.
  • To discuss the societal impact of CAP, including healthcare utilization and quality of life.
  • To evaluate current treatment strategies and future prevention methods for CAP.

Main Methods:

  • Literature review of studies on pediatric CAP.
  • Analysis of etiological factors and diagnostic limitations.
  • Assessment of treatment outcomes and prevention strategies.

Main Results:

  • CAP significantly impacts child health and families, leading to frequent medical visits and reduced quality of life.
  • Treatment algorithms have improved survival rates in developing countries.
  • Antimicrobial resistance presents a growing concern for the efficacy of current treatments.

Conclusions:

  • Effective management of pediatric CAP requires addressing diverse etiologies and diagnostic challenges.
  • The rise of antimicrobial resistance necessitates a re-evaluation of treatment strategies.
  • Pneumococcal vaccines offer a promising preventive measure against Streptococcus pneumoniae-related pneumonia.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...